Mutation and allelic loss of the PTEN/MMAC1 gene in primary and metastatic melanoma biopsies
- PMID: 10651986
- DOI: 10.1046/j.1523-1747.2000.00877.x
Mutation and allelic loss of the PTEN/MMAC1 gene in primary and metastatic melanoma biopsies
Abstract
The PTEN/MMAC1 gene on chromosome 10q23 encodes a lipid phosphatase with tumor-suppressive properties. Germline PTEN/MMAC1 mutations have been implicated as the predisposing factor in Cowden disease and other hamartoma syndromes, and somatic mutations and deletions have been identified in a wide range of human cancers, including 30-40% of metastatic melanoma cell lines. To study further the possible role of PTEN/MMAC1 in the pathogenesis and progression of malignant melanoma, we examined uncultured specimens from 16 primary and 61 metastatic tumors from 67 patients. Denaturing gradient gel electrophoresis was used to analyze systematically the coding region of PTEN/MMAC1 and revealed mutations in four of the metastatic samples (7%). Sequence analysis of the mutants identified a 1 bp frameshift insertion, a 2 bp frameshift deletion, an 11 bp frameshift deletion, and a single base substitution resulting in the generation of a premature stop codon. Analysis of two intragenic polymorphisms showed allelic loss in three of eight informative primary tumors (38%) and in 18 of 31 metastatic tumors (58%). One of the mutant cases showed allelic loss, suggesting that both PTEN/MMAC1 alleles were inactivated in this tumor. Altogether, these results suggest that mutation and deletion of PTEN/MMAC1 may contribute to the development and progression of malignant melanoma.
Similar articles
-
Identification of PTEN/MMAC1 alterations in uncultured melanomas and melanoma cell lines.Oncogene. 1998 Jul 2;16(26):3397-402. doi: 10.1038/sj.onc.1201881. Oncogene. 1998. PMID: 9692547
-
Alteration of the PTEN/MMAC1 gene locus in primary lung cancer with distant metastasis.Lung Cancer. 1999 Aug;25(2):87-93. doi: 10.1016/s0169-5002(99)00052-5. Lung Cancer. 1999. PMID: 10470842
-
Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues.Cancer Res. 1998 Jan 15;58(2):204-9. Cancer Res. 1998. PMID: 9443392
-
[Cowden disease].Nihon Rinsho. 2000 Jul;58(7):1479-83. Nihon Rinsho. 2000. PMID: 10921327 Review. Japanese.
-
Mutations of the human PTEN gene.Hum Mutat. 2000;16(2):109-22. doi: 10.1002/1098-1004(200008)16:2<109::AID-HUMU3>3.0.CO;2-0. Hum Mutat. 2000. PMID: 10923032 Review.
Cited by
-
Sphingolipid/Ceramide Pathways and Autophagy in the Onset and Progression of Melanoma: Novel Therapeutic _targets and Opportunities.Int J Mol Sci. 2019 Jul 12;20(14):3436. doi: 10.3390/ijms20143436. Int J Mol Sci. 2019. PMID: 31336922 Free PMC article. Review.
-
Nevi, dysplastic nevi, and melanoma: Molecular and immune mechanisms involving the progression.Tzu Chi Med J. 2021 Jul 16;34(1):1-7. doi: 10.4103/tcmj.tcmj_158_20. eCollection 2022 Jan-Mar. Tzu Chi Med J. 2021. PMID: 35233349 Free PMC article. Review.
-
Recent discoveries in the genetics of melanoma and their therapeutic implications.Arch Immunol Ther Exp (Warsz). 2007 Nov-Dec;55(6):363-72. doi: 10.1007/s00005-007-0043-5. Epub 2007 Dec 3. Arch Immunol Ther Exp (Warsz). 2007. PMID: 18060370 Free PMC article. Review.
-
Genetic alterations of PTEN in human melanoma.Cell Mol Life Sci. 2012 May;69(9):1475-91. doi: 10.1007/s00018-011-0878-0. Epub 2011 Nov 11. Cell Mol Life Sci. 2012. PMID: 22076652 Free PMC article. Review.
-
Ran signaling in melanoma: implications for the development of alternative therapeutic strategies.Cancer Lett. 2015 Feb 1;357(1):286-296. doi: 10.1016/j.canlet.2014.11.033. Epub 2014 Nov 20. Cancer Lett. 2015. PMID: 25444926 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials